TORONTO, July 03, 2024 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) today reported a summary of the voting results of its Annual General and Special Meeting of Shareholders (the “Meeting”).
Results of the Meeting
The Company is reporting the voting results of its Meeting held virtually on June 27, 2024. The summary of the results are as follows:
| Total Shares Voted: | 31,017,161 |
| Total Shares Issued and Outstanding: | 50,743,090 |
| Total Percentage of Shares Voted: | 61.126% |
1. Election of Directors
Each of the nominee directors listed in VitalHub’s management information circular dated May 8, 2024 was elected as a director as set forth in the table below:
| Name of Nominee | Vote For | % | Withheld Vote | % |
| Barry Tissenbaum | 28,318,085 | 91.714 | 2,558,552 | 8.286 |
| Roger Dent | 20,673,277 | 66.954 | 10,203,360 | 33.046 |
| Stephen Garrington | 30,874,109 | 99.992 | 2,528 | 0.008 |
| Dan Matlow | 30,875,410 | 99.996 | 1,227 | 0.004 |
| Francis Shen | 25,592,535 | 82.886 | 5,284,102 | 17.114 |
| Tony Shen | 28,314,335 | 91.701 | 2,562,302 | 8.299 |
2. Appointment and Compensation of Auditors
MNP LLP was appointed as the Company’s auditor and the directors were authorized to fix the auditor’s remuneration.
| Vote For | % | Withheld Vote | % | |
| MNP LLP | 30,997,496 | 99.937 | 19,665 | 0.063 |
3. Re-Approval of Stock Option Plan
The Company’s stock option plan was re-approved at the Meeting.
| Vote For | % | Withheld Vote | % | |
| Stock Option Plan | 23,393,980 | 75.766 | 7,482,657 | 24.234 |
4. Re-Approval of Deferred Share Unit Plan
The Company’s deferred share unit plan was re-approved at the Meeting.
| Vote For | % | Withheld Vote | % | |
| Deferred Share Unit Plan | 23,822,444 | 77.154 | 7,054,193 | 22.846 |
ABOUT VITALHUB
Software for Health and Human Services providers designed to simplify the user experience and optimize outcomes.
VitalHub is a leading software company dedicated to empowering Health and Human Services providers. Our clients include hospitals, regional health authorities, mental health and addictions services providers for children and adults, long-term care facilities, home health agencies, correctional services, and community and social services providers.
VitalHub’s comprehensive suite of SaaS solutions include:
The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently VitalHub serves more than 1,000 clients across Canada, USA, UK, Australia, the Middle East, and Europe.
VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The VitalHub team comprises more than 400 team members globally. The Company is publicly traded on the Toronto Stock Exchange (TSX) under the symbol “VHI” and on the OTC Markets OTCQX Exchange under the symbol “VHIBF”.
https://www.vitalhub.com/
CONTACT INFORMATION
VitalHub Corp.
Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | C$11.00 |
| Daily Change: | 0.10 0.92 |
| Daily Volume: | 382,862 |
| Market Cap: | C$577.280M |
December 17, 2024 November 13, 2024 October 30, 2024 August 08, 2024 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
